RecruitingNCT04866329

Female Fertility, Environmental Agents and Stress Oxidant

FERTilité féminine, Agents ENvironnementaux et Stress OXydant


Sponsor

University Hospital, Tours

Enrollment

500 participants

Start Date

Dec 8, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Synthetic products used in industrial, pharmaceutical, agro-alimentary or agricultural fields are found in our environment. Thus, humans could be simultaneously exposed to several of these pollutants. Furthermore, these environmental agents exert or could exert adverse actions on fertility, by altering gamete and embryo quality through endocrine disruptor effects or through increase in oxidative stress in gonads (cellular pathway known to be involved in several human reproductive pathologies). In this context, the objectives of the present project are to obtain descriptive and analytical data on woman and oocyte exposure to several environmental agents (bisphenols, ethynylestradiol and glyphosate). The relation between these pollutant measures in follicular fluid and urine (from women receiving follow-up of in vitro fertilization (IVF) protocol in the University hospital of Tours, France) and the oocyte quality, the IVF and pregnancy successes will be studied. Several oxidative stress biomarkers in blood and follicular fluid will be also measured for these women, who will complete a questionnaire on their lifestyles. Finally, thanks to in vitro approaches, the effects and the mechanisms of action (including oxidative stress) of these pollutants (alone or in cocktails) will be studied on granulosa cells from these patients.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood sample, Follicular fluid and granulosa cells sample, and others for people with female infertility. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood sample

Additional blood sampling at the end of ovarian stimulation monitoring (the eve of the oocyte pick-up)

OTHERUrine sample

Collection of the first urine in the morning on the day of the oocyte pick-up

OTHERFollicular fluid and granulosa cells sample

Collection of follicular fluid and granulosa cells during oocyte pick-up.


Locations(1)

Department of Reproductive Medicine and Biology, Univesity Hospital, Tours

Tours, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04866329


Related Trials